Close Menu

NEW YORK (GenomeWeb) – Danish in vitro diagnostics firm BioPorto announced today a deal with Roche for the global distribution of a neutrophil gelatinase-associated lipocalin (NGAL) test for use on the Cobas c 501 and Cobas c 502 analyzers.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.